Discover
TRDA
Entrada Therapeutics, Inc.
7.59
2 x 5.44
2 x 9.44
bid
ask
+
0.23
3.12%
2 @ 04:00 PM
7.51 -0.08 (1.05%)
| Ytd | -26.17% | |
| 1y | 6.75% |
7.32
day range
7.71
4.93
52 week range
16.45
| Open | 7.35 | Prev Close | 7.36 | Low | 7.32 | High | 7.71 | Mkt Cap | 294.65M |
| Vol | 272.56K | Avg Vol | 391.14K | EPS | -4.00 | P/E | N/A | Forward P/E | -5.54 |
| Beta | -0.27 | Short Ratio | 11.43 | Inst. Own | 80.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.46 | 200-d Avg | 9.53 | 1yr Est | 26.43 |
| Income Statement | |||
| Total Revenue | 875.00K | ||
| Revenues (USD) | 875.00K | ||
| Gross Profit | 875.00K | ||
| Operating Expenses | 43.18M | ||
| Research and Development Expense | 33.05M | ||
| Selling, General and Administrative Expense | 10.12M | ||
| Operating Income | -42.30M | ||
| Income Tax Expense | 38.00K | ||
| Net Income | -39.72M | ||
| Net Income Common Stock | -39.72M | ||
| Net Income Common Stock (USD) | -39.72M | ||
| Consolidated Income | -39.72M | ||
| Earnings per Basic Share | -0.95 | ||
| Earnings per Basic Share (USD) | -0.95 | ||
| Earnings per Diluted Share | -0.95 | ||
| Earning Before Interest & Taxes (EBIT) | -39.68M | ||
| Earning Before Interest & Taxes (USD) | -39.68M | ||
| Weighted Average Shares | 41.84M | ||
| Weighted Average Shares Diluted | 41.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 79.74M | ||
| Cash and Equivalents (USD) | 79.74M | ||
| Investments | 178.42M | ||
| Investments Current | 178.42M | ||
| Trade and Non-Trade Receivables | 787.00K | ||
| Current Assets | 266.87M | ||
| Property, Plant & Equipment Net | 65.26M | ||
| Total Assets | 335.52M | ||
| Debt Current | 4.28M | ||
| Total Debt | 49.75M | ||
| Current Liabilities | 19.20M | ||
| Debt Non-Current | 45.47M | ||
| Total Liabilities | 64.66M | ||
| Accumulated Retained Earnings (Deficit) | -312.81M | ||
| Accumulated Other Comprehensive Income | 246.00K | ||
| Shareholders Equity | 270.85M | ||
| Shareholders Equity (USD) | 270.85M | ||
| Assets Non-Current | 68.65M | ||
| Total Debt (USD) | 49.75M | ||
| Deferred Revenue | 254.00K | ||
| Liabilities Non-Current | 45.47M | ||
| Trade and Non-Trade Payables | 2.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 805.00K | ||
| Net Cash Flow from Financing | 100.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.61M | ||
| Capital Expenditure | -44.00K | ||
| Issuance (Purchase) of Equity Shares | 100.00K | ||
| Net Cash Flow from Investing | 26.99M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 27.03M | ||
| Net Cash Flow from Operations | -41.69M | ||
| Share Based Compensation | 4.74M | ||